×

Mesenchymal stem cell extract and its use

  • US 10,022,313 B2
  • Filed: 07/02/2014
  • Issued: 07/17/2018
  • Est. Priority Date: 02/17/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method for at least one of promoting the expression of hyaluronic acid (HA), elastin, collagen and/or reticulin in the skin, stimulating cell proliferation at the administered region, stimulating cells at the administered region to secrete a trophic factor, and stimulating endogenous hematopoietic progenitor cells (HPC) to gather and proliferate at the administered region in a subject, comprising administering to the subject an effective amount of a mesenchymal stem cell extract, wherein the mesenchymal stern cell extract is a supernatant comprising bone morphogenetic protein-7 (BMP-7), stromal cell-derived factor-1 (SDF- 1), vascular endothelial growth factor (VEGF), C-X-C chemokine receptor type-4 (CXCR4), brain-derived neurotrophic factor (BDNF) and interleukin-17 (IL-17), and the supernatant is provided by the following steps:

  • (1) mixing mesenchymal stem cells separated from an animal fat tissue with a proteolysis buffer containing NP40 lysis buffer, phenylmethanesulfonyl fluoride (PMSF), a protease inhibitor, p-glycerol phosphate and Na3V04, to lyse the cells and provide a cell lysate; and

    b(2) centrifuging the cell lysate at a temperature of no more than 4°

    C. to collect the supernatant.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×